News
Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts.
The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.
Pacira BioSciences Inc. (NASDAQ: PCRX) is one of the most undervalued small-cap stocks to buy according to analysts. On June ...
The biotech firm eliminated the need for surgical administration in the study by using an infusion catheter system in a cardiac cath lab.
KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results